H2020
SCREEN4CARE
Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 26,247,174
- EU contribution
- EUR 11,938,569
- Participants
- 21 from 12 countries
- Topic
- H2020_IMI2-2020-23-05
- Grant agreement
- 101034427
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Research Institute AG & Co KG | ATAustria | Participant | EUR 273,410 | PIC (1.00) |
| Sba Research Gemeinnutzige GmbH | ATAustria | Participant | EUR 309,750 | PIC (1.00) |
| Bulgarian Association for Personalized Medicine | BGBulgaria | Participant | EUR 113,471 | PIC (1.00) |
| Bulgarian Association for Promotion of Education and Science | BGBulgaria | Participant | EUR 113,250 | PIC (1.00) |
| Sitem-Insel AG | CHSwitzerland | Participant | EUR 308,218 | PIC (1.00) |
| Universitaet Bern | CHSwitzerland | Participant | EUR 659,656 | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 1,049,100 | PIC (1.00) |
| Eurice European Research and Project Office GmbH | DEGermany | Participant | EUR 485,375 | PIC (1.00) |
| Universitatsklinikum Bonn | DEGermany | Participant | EUR 0 | known name (0.95) |
| Universitatsklinikum Erlangen | DEGermany | Participant | EUR 490,000 | known name (0.97) |
| Findzebra Aps | DKDenmark | Participant | EUR 493,646 | PIC (1.00) |
| Consorcio Para la Explotacion del Centro Nacional de Analisis Genomico | ESSpain | Participant | EUR 388,544 | PIC (1.00) |
| Wallac OY | FIFinland | Participant | EUR 0 | PIC (1.00) |
| Centre Hospitalier Reg Universitaire Dijon | FRFrance | Participant | EUR 142,861 | PIC (1.00) |
| Eurordis - Rare Diseases Europe | FRFrance | Participant | EUR 736,895 | PIC (1.00) |
| Lysogene | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Illumina Cambridge Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Ptc Therapeutics International Limited | IEIreland | Participant | EUR 0 | PIC (1.00) |
| Gnx Data Systems Ltd | ILIsrael | Participant | EUR 392,000 | PIC (1.00) |
| Consorzio Futuro in Ricerca | ITItaly | Participant | EUR 120,000 | PIC (1.00) |
| Ospedale Pediatrico Bambino Gesu | ITItaly | Participant | EUR 753,848 | PIC (1.00) |
Changes of the consortium
First seen on with 21 participants from 12 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.